ArticleScientific reports2025
Esophagectomy enhances hypertension remission and metabolism via weight loss in esophageal Cancer patients with hypertension.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Previous studies have documented hypertension remission following bariatric surgeries and other gastrointestinal surgeries, but the impact of esophagectomy on hypertension remains unclear. This study assesses whether esophagectomy induces hypertension remission in esophageal cancer patients and identifies influencing factors. This retrospective study included 66 esophageal cancer patients with hypertension who underwent esophagectomy (2017-2020). Patients were classified into remission and non-remission groups based on postoperative hypertension status. Preoperative and six-month postoperative data (age, weight, BMI, hypertension duration, metabolic indicators) were analyzed. Independent predictors of remission were identified via binary logistic regression. At six months post-esophagectomy, 34.8% achieved complete remission, 30.4% showed improvement, and 34.8% had no remission. Significant reductions in weight, BMI, systolic blood pressure (p < 0.001), and LDL (p = 0.04), along with increased HDL levels (p < 0.001), were observed. Patients in the remission group were younger (p = 0.028), had shorter hypertension duration (p = 0.013), and lower HDL levels (p = 0.031). Age, %TWL, and hypertension duration were independent predictors of remission. Esophagectomy in esophageal cancer patients facilitates weight loss, improves lipid profiles, and promotes hypertension remission, primarily through postoperative weight loss, particularly in younger patients with shorter hypertension duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.